table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Point-of-Care Molecular Diagnostics Market Size Analysis from 2022 to 2027
1.5.1 Global Point-of-Care Molecular Diagnostics Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Point-of-Care Molecular Diagnostics Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Point-of-Care Molecular Diagnostics Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Point-of-Care Molecular Diagnostics Industry Impact
Chapter 2 Global Point-of-Care Molecular Diagnostics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Point-of-Care Molecular Diagnostics (Volume and Value) by Type
2.1.1 Global Point-of-Care Molecular Diagnostics Consumption and Market Share by Type (2016-2021)
2.1.2 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Type (2016-2021)
2.2 Global Point-of-Care Molecular Diagnostics (Volume and Value) by Application
2.2.1 Global Point-of-Care Molecular Diagnostics Consumption and Market Share by Application (2016-2021)
2.2.2 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Application (2016-2021)
2.3 Global Point-of-Care Molecular Diagnostics (Volume and Value) by Regions
2.3.1 Global Point-of-Care Molecular Diagnostics Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Point-of-Care Molecular Diagnostics Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Point-of-Care Molecular Diagnostics Consumption by Regions (2016-2021)
4.2 North America Point-of-Care Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Point-of-Care Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Point-of-Care Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Point-of-Care Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Point-of-Care Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Point-of-Care Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Point-of-Care Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Point-of-Care Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.10 South America Point-of-Care Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Point-of-Care Molecular Diagnostics Market Analysis
5.1 North America Point-of-Care Molecular Diagnostics Consumption and Value Analysis
5.1.1 North America Point-of-Care Molecular Diagnostics Market Under COVID-19
5.2 North America Point-of-Care Molecular Diagnostics Consumption Volume by Types
5.3 North America Point-of-Care Molecular Diagnostics Consumption Structure by Application
5.4 North America Point-of-Care Molecular Diagnostics Consumption by Top Countries
5.4.1 United States Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
5.4.2 Canada Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
5.4.3 Mexico Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 6 East Asia Point-of-Care Molecular Diagnostics Market Analysis
6.1 East Asia Point-of-Care Molecular Diagnostics Consumption and Value Analysis
6.1.1 East Asia Point-of-Care Molecular Diagnostics Market Under COVID-19
6.2 East Asia Point-of-Care Molecular Diagnostics Consumption Volume by Types
6.3 East Asia Point-of-Care Molecular Diagnostics Consumption Structure by Application
6.4 East Asia Point-of-Care Molecular Diagnostics Consumption by Top Countries
6.4.1 China Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
6.4.2 Japan Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
6.4.3 South Korea Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 7 Europe Point-of-Care Molecular Diagnostics Market Analysis
7.1 Europe Point-of-Care Molecular Diagnostics Consumption and Value Analysis
7.1.1 Europe Point-of-Care Molecular Diagnostics Market Under COVID-19
7.2 Europe Point-of-Care Molecular Diagnostics Consumption Volume by Types
7.3 Europe Point-of-Care Molecular Diagnostics Consumption Structure by Application
7.4 Europe Point-of-Care Molecular Diagnostics Consumption by Top Countries
7.4.1 Germany Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.2 UK Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.3 France Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.4 Italy Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.5 Russia Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.6 Spain Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.7 Netherlands Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.8 Switzerland Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.9 Poland Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 8 South Asia Point-of-Care Molecular Diagnostics Market Analysis
8.1 South Asia Point-of-Care Molecular Diagnostics Consumption and Value Analysis
8.1.1 South Asia Point-of-Care Molecular Diagnostics Market Under COVID-19
8.2 South Asia Point-of-Care Molecular Diagnostics Consumption Volume by Types
8.3 South Asia Point-of-Care Molecular Diagnostics Consumption Structure by Application
8.4 South Asia Point-of-Care Molecular Diagnostics Consumption by Top Countries
8.4.1 India Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
8.4.2 Pakistan Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Point-of-Care Molecular Diagnostics Market Analysis
9.1 Southeast Asia Point-of-Care Molecular Diagnostics Consumption and Value Analysis
9.1.1 Southeast Asia Point-of-Care Molecular Diagnostics Market Under COVID-19
9.2 Southeast Asia Point-of-Care Molecular Diagnostics Consumption Volume by Types
9.3 Southeast Asia Point-of-Care Molecular Diagnostics Consumption Structure by Application
9.4 Southeast Asia Point-of-Care Molecular Diagnostics Consumption by Top Countries
9.4.1 Indonesia Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
9.4.2 Thailand Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
9.4.3 Singapore Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
9.4.4 Malaysia Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
9.4.5 Philippines Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
9.4.6 Vietnam Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
9.4.7 Myanmar Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 10 Middle East Point-of-Care Molecular Diagnostics Market Analysis
10.1 Middle East Point-of-Care Molecular Diagnostics Consumption and Value Analysis
10.1.1 Middle East Point-of-Care Molecular Diagnostics Market Under COVID-19
10.2 Middle East Point-of-Care Molecular Diagnostics Consumption Volume by Types
10.3 Middle East Point-of-Care Molecular Diagnostics Consumption Structure by Application
10.4 Middle East Point-of-Care Molecular Diagnostics Consumption by Top Countries
10.4.1 Turkey Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.3 Iran Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.5 Israel Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.6 Iraq Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.7 Qatar Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.8 Kuwait Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.9 Oman Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 11 Africa Point-of-Care Molecular Diagnostics Market Analysis
11.1 Africa Point-of-Care Molecular Diagnostics Consumption and Value Analysis
11.1.1 Africa Point-of-Care Molecular Diagnostics Market Under COVID-19
11.2 Africa Point-of-Care Molecular Diagnostics Consumption Volume by Types
11.3 Africa Point-of-Care Molecular Diagnostics Consumption Structure by Application
11.4 Africa Point-of-Care Molecular Diagnostics Consumption by Top Countries
11.4.1 Nigeria Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
11.4.2 South Africa Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
11.4.3 Egypt Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
11.4.4 Algeria Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
11.4.5 Morocco Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 12 Oceania Point-of-Care Molecular Diagnostics Market Analysis
12.1 Oceania Point-of-Care Molecular Diagnostics Consumption and Value Analysis
12.2 Oceania Point-of-Care Molecular Diagnostics Consumption Volume by Types
12.3 Oceania Point-of-Care Molecular Diagnostics Consumption Structure by Application
12.4 Oceania Point-of-Care Molecular Diagnostics Consumption by Top Countries
12.4.1 Australia Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
12.4.2 New Zealand Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 13 South America Point-of-Care Molecular Diagnostics Market Analysis
13.1 South America Point-of-Care Molecular Diagnostics Consumption and Value Analysis
13.1.1 South America Point-of-Care Molecular Diagnostics Market Under COVID-19
13.2 South America Point-of-Care Molecular Diagnostics Consumption Volume by Types
13.3 South America Point-of-Care Molecular Diagnostics Consumption Structure by Application
13.4 South America Point-of-Care Molecular Diagnostics Consumption Volume by Major Countries
13.4.1 Brazil Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.2 Argentina Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.3 Columbia Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.4 Chile Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.5 Venezuela Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.6 Peru Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.8 Ecuador Point-of-Care Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Point-of-Care Molecular Diagnostics Business
14.1 Danaher Corporation
14.1.1 Danaher Corporation Company Profile
14.1.2 Danaher Corporation Point-of-Care Molecular Diagnostics Product Specification
14.1.3 Danaher Corporation Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Johnson and Johnson
14.2.1 Johnson and Johnson Company Profile
14.2.2 Johnson and Johnson Point-of-Care Molecular Diagnostics Product Specification
14.2.3 Johnson and Johnson Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 BioMerieux
14.3.1 BioMerieux Company Profile
14.3.2 BioMerieux Point-of-Care Molecular Diagnostics Product Specification
14.3.3 BioMerieux Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 F. Hoffmann-La Roche AG
14.4.1 F. Hoffmann-La Roche AG Company Profile
14.4.2 F. Hoffmann-La Roche AG Point-of-Care Molecular Diagnostics Product Specification
14.4.3 F. Hoffmann-La Roche AG Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Abbott Laboratories, Bayer Healthcare
14.5.1 Abbott Laboratories, Bayer Healthcare Company Profile
14.5.2 Abbott Laboratories, Bayer Healthcare Point-of-Care Molecular Diagnostics Product Specification
14.5.3 Abbott Laboratories, Bayer Healthcare Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Becton, Dickinson and Company
14.6.1 Becton, Dickinson and Company Company Profile
14.6.2 Becton, Dickinson and Company Point-of-Care Molecular Diagnostics Product Specification
14.6.3 Becton, Dickinson and Company Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Cepheid, Inc.
14.7.1 Cepheid, Inc. Company Profile
14.7.2 Cepheid, Inc. Point-of-Care Molecular Diagnostics Product Specification
14.7.3 Cepheid, Inc. Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Bio-Rad Laboratories, Inc.
14.8.1 Bio-Rad Laboratories, Inc. Company Profile
14.8.2 Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Product Specification
14.8.3 Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Point-of-Care Molecular Diagnostics Market Forecast (2022-2027)
15.1 Global Point-of-Care Molecular Diagnostics Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Point-of-Care Molecular Diagnostics Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Point-of-Care Molecular Diagnostics Value and Growth Rate Forecast (2022-2027)
15.2 Global Point-of-Care Molecular Diagnostics Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Point-of-Care Molecular Diagnostics Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Point-of-Care Molecular Diagnostics Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Point-of-Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Point-of-Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Point-of-Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Point-of-Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Point-of-Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Point-of-Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Point-of-Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Point-of-Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Point-of-Care Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Point-of-Care Molecular Diagnostics Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Point-of-Care Molecular Diagnostics Consumption Forecast by Type (2022-2027)
15.3.2 Global Point-of-Care Molecular Diagnostics Revenue Forecast by Type (2022-2027)
15.3.3 Global Point-of-Care Molecular Diagnostics Price Forecast by Type (2022-2027)
15.4 Global Point-of-Care Molecular Diagnostics Consumption Volume Forecast by Application (2022-2027)
15.5 Point-of-Care Molecular Diagnostics Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
